ゲノム編集/ゲノム工学の世界市場予測（～2021年）：細胞株工学、動物遺伝子工学、植物遺伝子工学...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.3.1 Market Data Validation and Triangulation
2.3.2 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Genome Editing: Market Overview
4.2 Geographic Analysis: Genome Editing Market, By Application (2016)
4.3 Market Size, By Technology, 2016 vs 2021
4.4 Market Size, By Application, 2016 vs 2021
4.5 Market Size, By End User, 2016 vs 2021
4.6 Geographical Snapshot of the Genome Editing Market

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 High Prevalence Rate of Infectious Diseases and Cancer Among Patients
5.2.1.3 Technological Advancements
5.2.1.4 Increase in Demand for Synthetic Genes
5.2.1.5 Rise in Production of Genetically Modified Crops
5.2.1.6 Increasing Awareness About Genomics
5.2.1.7 New Product Launches By Industry Players
5.2.2 Restraints
5.2.2.1 High Cost of Genomic Equipment
5.2.2.2 Adverse Public Perception Related to Genetic Research
5.2.3 Opportunities
5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
5.2.3.2 Emerging Markets in Developing Countries
5.2.4 Challenges
5.2.4.1 Off-Target Effect of CRISPR
5.2.4.2 Shortage of Trained Professionals

6 Global Genome Editing/Engineering Market, By Technology (Page No. – 48)
6.1 Introduction
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 Antisense
6.6 Other Technologies

7 Global Genome Editing/Genome Engineering Market, By Application (Page No. – 61)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Animal Genetic Engineering
7.4 Plant Genetic Engineering
7.5 Other Applications

8 Global Genome Editing/Engineering Market, By End User (Page No. – 73)
8.1 Introduction
8.2 Biotechnology & Pharmaceutical Companies
8.3 Academic & Government Research Institutes
8.4 Contract Research Organizations

9 Genome Editing/Genome Engineering Market, By Region (Page No. – 81)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Development of Gene Therapy in the U.S.
9.2.1.2 Increasing Use of Gm Crops
9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States
9.2.1.4 Genome Editing Conferences in the U.S.
9.2.1.5 Rising Availability of Research Grants and Funding
9.2.1.6 Genome Editing Standards Workshop in the U.S.
9.2.1.7 Increasing Prevalence of Cancer
9.2.1.8 Strategic Developments in the U.S. Market
9.2.2 Canada
9.2.2.1 Availability of Research Funding in Canada
9.2.2.2 Rising Incidence of Cancer
9.2.2.3 Gapp to Intensify Genomic R&D
9.3 Europe
9.3.1 Conferences and Meetings in Europe
9.3.2 U.K.
9.3.2.1 Increased Funds, and Grants By Government Bodies
9.3.2.2 100,000 Genomes Project in U.K.
9.3.3 Germany
9.3.3.1 Availability of Funding for Life Science Research
9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany
9.3.3.3 RoE
9.3.3.4 Spain’s Focus on Research
9.3.3.5 Growth in the Italian Biotech and Pharma Sectors
9.3.3.6 Growing Research Investments in Sweden & Denmark
9.4 Asia-Pacific
9.4.1 China
9.4.1.1 High Intensity of R&D Activities in China
9.4.1.2 Growing Focus of Global Companies on China
9.4.2 Japan
9.4.2.1 Involvement of Industry Players in the Japanese Market: Significant Developments
9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
9.4.2.3 Focus on Cancer Research and Treatment
9.4.3 India
9.4.3.1 Emergence of Local Players in India
9.4.3.2 Growth of the Pharmaceutical Industry in India
9.4.3.3 Development of Bio-Clusters to Boost India’s Biotechnology Industry
9.4.4 RoAPAC
9.4.4.1 Australia: Availability of Financial Support for Research
9.4.4.2 Genome Asia 100k Initiative
9.4.4.3 Crop Research Initiatives in Asia
9.5 RoW
9.5.1 Genetic Testing and Genomic Analysis in the Middle East
9.5.2 Brazil: Investments in Research and Innovation Centers and Conferences & Workshops
9.5.3 Rising Prevalence of Hiv, Cancer in Africa

10 Competitive Landscape (Page No. – 119)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Introduction
10.2.2 Thermo Fisher Scientific, Inc.
10.2.3 Merck KGaA
10.2.4 Horizon Discovery Group PLC
10.3 Competitive Situation and Trends
10.3.1 Agreements, Collaborations, and Partnerships
10.3.2 Product & Service Launches
10.3.3 Acquisitions
10.3.4 Expansions
10.3.5 Other Strategies
10.4 Strategic Benchmarking

11 Company Profiles (Page No. – 131)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Horizon Discovery Group PLC
11.4 Genscript USA Inc.
11.5 Sangamo Biosciences, Inc.
11.6 Integrated DNA Technologies, Inc.
11.7 Lonza Group Ltd.
11.8 New England Biolabs, Inc.
11.9 Origene Technologies, Inc.
11.10 Transposagen Biopharmaceuticals, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 152)
12.1 Discussion Guide
12.2 Other Developments, By Company (2013–2016)
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports